If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Regulatory News (TATE)

Share Price Information for Tate & Lyle (TATE)

Share Price is delayed by 15 minutes
Get Live Data
559.00    3.00 (0.54%)
Bid:
556.50
Ask:
557.00
Spread: 0.50 (0.09%)
Market Cap: £2.47b
TATE Live PriceLast checked at - London Stock Exchange

Intraday Tate & Lyle Share Chart

Director/PDMR Shareholding

22 Jun 2016 13:49

Tate & Lyle PLC

Director/PDMR Shareholding

Tate & Lyle PLC (the ‘Company’) has been informed that a grant of options and awards over the Company’s ordinary shares of 25 pence each in the capital of the Company (‘Shares’) was made today to Executive Directors and Persons Discharging Managerial Responsibilities (‘PDMR’) as detailed in the table below:

Name Role Form of award (Option/ Conditional Award) Deferred Bonus1 Conditional Share Awards programme2
Rowan Adams PDMR Option 12,897 70,000
Javed Ahmed Executive Director Option 42,742 -
Joan Braca PDMR Conditional Award 9,369 90,000
Robert Gibber PDMR Option 18,524 80,000
Nick Hampton Executive Director Option 29,368 -
Rob Luijten PDMR Option 15,289 80,000
Gabriella Parisse PDMR Conditional Award 7,993 70,000
Pierre Schoumacher PDMR Conditional Award 11,755 70,000
James Stutelberg PDMR Conditional Award 12,842 90,000

1 Options and awards for the Deferred Bonus are awarded under the Tate & Lyle Group Bonus Plan (‘GBP’) in respect of the year ended 31 March 2016. No consideration is payable for the grant or exercise of the options or awards under the GBP. Further information on the operation of the GBP is provided in the Annual Report 2016.

2 Options and awards under the Conditional Share Award programme will only vest to the extent that certain Company-based financial performance criteria are satisfied over a performance period which runs from 1 April 2016 to 31 March 2017. No consideration is payable for the grant or exercise of the options or awards. Options and awards will be subject to a 12-month deferral period and continued employment to 31 March 2018.

All the above transactions took place in London.

This notification is made in accordance with DTR 3.1.4R(1)(a) of the FCA’s Disclosure and Transparency Rules.

Lucie Gilbert

Company Secretary

22 June 2016

View source version on businesswire.com: http://www.businesswire.com/news/home/20160622005771/en/

Copyright Business Wire 2016

Date   Source Headline
12th Jul 202411:00 amRNSBlock listing Interim Review
11th Jul 20245:30 pmRNSTransaction in Own Shares
10th Jul 20245:41 pmRNSTransaction in Own Shares
9th Jul 20245:24 pmRNSTransaction in Own Shares
8th Jul 20245:41 pmRNSTransaction in Own Shares
5th Jul 20245:49 pmRNSTransaction in Own Shares
5th Jul 20242:00 pmRNSDirector/PDMR Shareholding
4th Jul 20245:40 pmRNSTransaction in Own Shares
3rd Jul 20245:29 pmRNSTransaction in Own Shares
2nd Jul 20245:32 pmRNSTransaction in Own Shares
2nd Jul 202411:30 amRNSHolding(s) in Company
1st Jul 20245:29 pmRNSTransaction in Own Shares
1st Jul 202412:30 pmRNSTotal Voting Rights
28th Jun 20245:59 pmRNSTransaction in Own Shares
27th Jun 20245:37 pmRNSTransaction in Own Shares
27th Jun 20244:30 pmRNSCompletes sale of remaining interest in Primient
27th Jun 20243:30 pmRNSHolding(s) in Company
26th Jun 20245:38 pmRNSTransaction in Own Shares
25th Jun 20245:50 pmRNSTransaction in Own Shares
24th Jun 20245:35 pmRNSTransaction in Own Shares
24th Jun 20243:30 pmRNSHolding(s) in Company
21st Jun 20245:45 pmRNSTransaction in Own Shares
21st Jun 20242:45 pmRNSUpdate to the Notice of AGM 2024
20th Jun 20246:03 pmRNSTransaction in Own Shares
20th Jun 20247:05 amRNSLaunch of Share Buyback
20th Jun 20247:00 amRNSCombination of Tate & Lyle and CP Kelco
4th Jun 20245:22 pmRNSAnnual Financial Report and Notice of AGM
4th Jun 202411:00 amRNSDirector/PDMR Shareholding
3rd Jun 202412:00 pmRNSTotal Voting Rights
30th May 202412:15 pmRNSHolding(s) in Company
23rd May 20247:00 amRNSFinal Results
23rd May 20247:00 amRNSSale of remaining interest in Primient JV to KPS
20th May 20241:00 pmRNSDirectorate Change
17th May 20243:30 pmRNSHolding(s) in Company
14th May 20243:30 pmRNSHolding(s) in Company
13th May 202410:00 amRNSHolding(s) in Company
8th May 20243:15 pmRNSHolding(s) in Company
1st May 20242:30 pmRNSTotal Voting Rights
25th Apr 20243:45 pmRNSHolding(s) in Company
24th Apr 20247:00 amRNSDirectorate Change
22nd Apr 20242:30 pmRNSDirector/PDMR Shareholding
19th Apr 202410:15 amRNSHolding(s) in Company
17th Apr 20244:15 pmRNSHolding(s) in Company
17th Apr 202410:30 amRNSHolding(s) in Company
15th Apr 202410:30 amRNSHolding(s) in Company
10th Apr 20243:45 pmRNSHolding(s) in Company
8th Apr 202411:15 amRNSHolding(s) in Company
5th Apr 20243:45 pmRNSHolding(s) in Company
4th Apr 20244:15 pmRNSHolding(s) in Company
4th Apr 202412:30 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.